NCT05792358Completed
Wet Cupping Therapy in Ankylosing Spondylitis
Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Quasi- Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 109 (actual)
- First submitted
- 7 Mar 2023
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- Karabuk University
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT05792358
What you commit to
- Study type: Interventional
- Participants enrolled: 109
- From 1 Jun 2024 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having received WCT within the previous 3 months
- Any change in AS medication during the study period
Other illness
- Severe uncontrolled comorbidities (e.g., advanced cardiovascular disease, uncontrolled diabetes, active malignancy, severe psychiatric illness)
- Failure to complete either baseline or follow-up visits
Lab values
- Contraindications to WCT (hemoglobin \<9.5 g/dL, known bleeding or coagulation disorders, anticoagulant use or antiplatelet therapy other than aspirin \<100 mg, INR \>1.5, etc.)
Other
- Pregnancy or breastfeeding
Who the study is looking for
- Age between 18-65 years
- Confirmed diagnosis of ankylosing spondylitis (AS) according to the modified New York criteria or the ASAS classification criteria for axial spondyloarthritis
- Active disease at enrolment, confirmed by a PM\&R specialist
- Written informed consent and compliance with the study protocol
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karabuk University Coordinator of this site? Confirm its status | Karabük | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.